Referral Equity Program
Tap into Pacaso’s growth with equity rewards.
How it works
Pacaso’s Referral Equity Program (REP) is an innovative incentive program for real estate agents who are residents of the USA.
- Agents receive 500 restricted stock units (RSUs) for each closed buyer referral, on top of their commission.
- You don’t need to sign up — your equity bonus will be automatically granted at closing!
- Read our FAQs below for additional details.
Have an interested buyer?
Frequently asked questions
Who is eligible to participate, and how do I sign up?
Any agent who closes on a buy-side share of a Pacaso is eligible. You do not need to enrol or register; your equity bonus will be automatically applied.
How do I sign up for the equity program?
No formal sign up is necessary. Simply submit your referral through our submission form, and we’ll send over a referral agreement.
How is the equity bonus tracked?
Your commission and equity bonus* is automatically tracked when you submit your referral through our submission form, and will be granted at closing.
*Equity grants subject to terms in your market.
Will I still be paid commission?
Yes. Buyer’s agents earn 4% referral commission when selling a Pacaso. The equity grant is an additional incentive.
Is this program available to agents who bring Pacaso listings?
No. This offer is exclusively for agents who bring buyers and close buy-side transactions.
What markets are you in?
Pacaso operates in top second home destinations across the USA and in Europe, with plans to expand globally. You can find our active markets here.
I sold a Pacaso in the past. Is this program retroactive?
This is a forward-looking program. Agents are eligible to receive the equity bonus for referrals that close on or after June 9, 2021.
What is the dollar value of each award, and how will the stock be priced?
Because Pacaso is currently a private company, the value of the equity is a moving target. Our 409A valuation puts Pacaso’s common stock at USD $0.86/share. This is a tax valuation. When we sold preferred stock at our $1B valuation in March 2021, that deal was done at a per-share price of $4.15, which is a helpful indicator of how the investment community is valuing the company. Program participants interested in estimating the value of their RSUs can use this preferred stock price as a reference point, but until we are public, the ultimate value remains hypothetical.